Faricimab - Roche
At a glance
- Drug Originator Roche
- Drug Class Bispecific antibodies; Eye disorder therapies
- Mechanism of Action Angiopoietin-2 inhibitors; Vascular endothelial growth factor A inhibitors
- USA Patent Applicants GENENTECH INC
- USA Patents 1
- BLAs 1
- International Patents 5
Disclaimer